IMMUNOPRECISE ANTIBODIES LTD (IPA)
CA45257F2008 - Common Stock
InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024
IPA stock results show that ImmunoPrecise Antibodies missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
IPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ImmunoPrecise Antibodies (NASDAQ:IPA) just reported results for the third quart...
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024
IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ImmunoPrecise Antibodies (NASDAQ:IPA) just reported results for the second quar...
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
Why Is Carbon Revolution (CREV) Stock Down Today?
Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call.
Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?
ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning!
ImmunoPrecise Antibodies prices $1.1M secondary offering of common shares (NASDAQ:IPA)
ImmunoPrecise Antibodies sets the price for its public offering, aiming to raise $1.1M for R&D, expansion, and general corporate purposes.
IPA Announces Pricing of $1.1 Million Public Offering of Common Shares
IPA Announces Proposed Public Offering of Common Shares
ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call
BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research
IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
